Advances in Head and Neck Cancers: Nasopharyngeal and Oral Cancers

Presented by:
Jessica L. Geiger
Search for other papers by Jessica L. Geiger in
Current site
Google Scholar
PubMed Close
 MD
,
Aditya Juloori
Search for other papers by Aditya Juloori in
Current site
Google Scholar
PubMed Close
 MD
, and
Susan D. McCammon
Search for other papers by Susan D. McCammon in
Current site
Google Scholar
PubMed Close
 MD, PhD
Volume/Issue:
Volume 23: Issue Supplement
Online Publication Date:
27 May 2025
DOI:
https://doi.org/10.6004/jnccn.2025.5014
Restricted access

Although surgery is a key component of the curative approach to treating patients with head and neck cancers, the function and complex anatomy of the tumor location make interdisciplinary communication and management paramount. Radiation therapy also remains a mainstay of treatment, and immunotherapy is emerging as a future option for patients with select head and neck cancers.

Disclosures: Dr. Geiger has disclosed receiving grant/research support from Astellas Pharma US, Inc., EMD Serono, Janssen Pharmaceutica Products, and Merck & Co., Inc.; and receiving consulting fees from AVEO Pharmaceuticals, Inc. and EMD Serono. Dr. Juloori has disclosed receiving grant/research support from AstraZeneca Pharmaceuticals LP; and receiving consulting fees from AstraZeneca Pharmaceuticals LP, EMD Serono, GSK plc, and Regeneron Pharmaceuticals, Inc. Dr. McCammon has disclosed no relevant financial relationships.

Correspondence: Jessica L. Geiger, MD, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Avenue, CA-60, Cleveland, OH 44195. Email: geigerj@ccf.org;
Aditya Juloori, MD, The UChicago Medicine Comprehensive Cancer Center, 600 North Lake Shore Drive, Unit 3402, Chicago, IL 60611. Email: ajuloori@uchicagomedicine.org; and
Susan D. McCammon, MD, PhD, O’Neal Comprehensive Cancer Center at UAB, 1720 2nd Avenue South, FOT 1155, Birmingham, AL 35294. Email: smccammon@uabmc.edu
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1.

    Zhang Y, Chen L, Hu GQ, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med 2019;381:1124–1135.

  • 2.

    Liu X, Zhang Y, Yang KY, et al. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet 2024;403:2720–2731.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Liang YL, Liu X, Shen LF, et al. Adjuvant PD-1 blockade with camrelizumab for nasopharyngeal carcinoma: the DIPPER randomized clinical trial. JAMA 2025;333:1589–1598.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    You R, Liu YP, Xie YL, et al. Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. Lancet 2023;401:917–927.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    You R, Liu YP, Huang PY, et al. Efficacy and safety of locoregional radiotherapy with chemotherapy vs chemotherapy alone in de novo metastatic nasopharyngeal carcinoma: a multicenter phase 3 randomized clinical trial. JAMA Oncol 2020;6:1345–1352.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Mai HQ, Chen QY, Chen D, et al. Toripalimab Plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: the JUPITER-02 randomized clinical trial. JAMA 2023;330:1961–1970.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Wu SS, Chen B, Fleming CW, et al. Nasopharyngeal cancer: incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution. Head Neck 2022;44:851–861.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Lydiatt WM, Patel SG, O’Sullivan B, et al. Head and neck cancers—major changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA Cancer J Clin 2017;67:122–137.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Eskander A, Dziegielewski PT, Patel MR, et al. Oral cavity cancer surgical and nodal management: a review from the American Head and Neck Society. JAMA Otolaryngol Head Neck Surg 2024;150:172–178.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Amit M, Na’ara S, Leider-Trejo L, et al. Improving the rate of negative margins after surgery for oral cavity squamous cell carcinoma: a prospective randomized controlled study. Head Neck 2016;38:E1803–1809.

    • PubMed
    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2025 by the National Comprehensive Cancer Network 2025
Article Category:
Abstract
Print Publication Date:
01 May 2025
Online Publication Date:
27 May 2025

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2063 2063 2063
PDF Downloads 123 123 123
EPUB Downloads 0 0 0